Features
News roundups
Announcements
Most Viewed      Most Discussed

Nearly 40 years after surgeons first operated on fetuses to cure devastating abnormalities, researchers have taken the first step toward curing genetic disease before birth via genome editing: scientists reported on Monday

Quick Read

The U.S. Department of Health and Human Services (HHS) in Washington, D.C., which funds much of the nation’s biomedical research, has launched a “comprehensive review” of human fetal tissue research, to ensure that it’s complying with laws and regulations

Quick Read

There is a general shortage of information about the safety of medications used during pregnancy—largely because any woman who is pregnant, was recently pregnant, or might get pregnant is barred from participating in most of the clinical trials that evaluate drug safety and efficacy

Quick Read

Vulnerable groups, such as children, prisoners and people with limited mental capacity, are usually excluded from drug trials. And, until quite recently, it was considered unethical to test drugs on pregnant women, too… But the tide is turning

Quick Read

Clinical trial will compare three antiretroviral drug regimens. It will provide data on the use of these newer drugs during pregnancy, helping to ensure that women living with HIV and their infants receive the best available treatments

Quick Read

Advocates are tracking new developments in neonatal research and technology—and transforming one of America’s most contentious debates. With comments from our Debra Mathews

Quick Read

The womb was thought to be sterile, but some scientists argue that it’s where the microbiome begins

Quick Read

Womb transplants are again in the news as Richard Paulson, president of the American Society for Reproductive Medicine (ASRM), said there was no reason to believe that the treatment could not work for transgender women at recent conference in Texas

Quick Read